Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines : Med e-News


Published: 19Jun2020

Live 2020 . Saint-Gobain Life Sciences and Kanyr Pharma partner with clinical experts at the Research Institute of McGill University Health Centre and engineers at McGill to develop new cell culture technologies.

Back to top